Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 Life Science Investing
KORU Medical Systems Receives FDA 510 Clearance for Delivery of RYSTIGGO® , Expanding Label for FreedomEDGE® Infusion System Life Science Investing
Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor Life Science Investing
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension Pharmaceutical Investing
BioVaxys Reports Positive Phase 2 Data for Maveropepimut + Pembrolizumab and Low-Dose Cyclophosphamide in Metastatic Bladder Cancer Life Science Investing
AbbVie Launches Love in Mind to Spotlight the Emotional Impact of Migraine on Romantic Relationships Pharmaceutical Investing
